<ѻýҕl>Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGITѻýҕl> News, features, and commentary about cancer-related issues Jul 05, 2024
<ѻýҕl>Belantamab Mafodotin: The Comeback Drug in Multiple Myelomaѻýҕl> Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials Jul 05, 2024 video
<ѻýҕl>Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?ѻýҕl> U.S. clinics market oligonucleotide therapy for a wide range of conditions, without much evidence Jul 05, 2024
<ѻýҕl>More Data Link Obesity to Better Survival for Cancer Patients on Immunotherapyѻýҕl> Higher BMI also associated with improvements in functional outcomes in this setting Jul 04, 2024
<ѻýҕl>Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancerѻýҕl> Discussion highlights insights from the LAURA trial and others on emerging treatments Jul 03, 2024 video
<ѻýҕl>Vapers May Be Less Likely to Undergo Lung Cancer Screeningѻýҕl> "Former smokers who use e-cigarettes remain at increased risk of lung cancer," researchers say Jul 02, 2024
<ѻýҕl>PSMA PET Beats MRI in Prostate Cancer Staging Studyѻýҕl> Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors Jul 02, 2024
<ѻýҕl>Pivotal Studies in Double-Expressor DLBCL Yield Divergent Resultsѻýҕl> R-CHOP plus venetoclax falls short, while R-CHOP with HDAC inhibitor shows promise Jul 02, 2024 video
<ѻýҕl>Screening Mammography Performance Improved, Workload Decreased With AI Assistanceѻýҕl> How European data play out in U.S. mammography environment remains to be seen Jul 01, 2024
<ѻýҕl>Neuromuscular Training Decreased Incidence of Chemo-Induced Peripheral Neuropathyѻýҕl> Incidence significantly reduced with two types of exercises versus usual care Jul 01, 2024
<ѻýҕl>Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trialsѻýҕl> News, features, and commentary about cancer-related issues Jun 28, 2024
<ѻýҕl>Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteriaѻýҕl> No difference in adverse events, clinical benefit, OS for patients with or without waivers Jun 27, 2024
<ѻýҕl>Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complicationsѻýҕl> Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
<ѻýҕl>CAR T-Cell Therapy in Functional High-Risk Multiple Myelomaѻýҕl> Joseph Mikhael, MD, leads a discussion on the subgroup analysis of CARTITUDE-4 Jun 27, 2024 video
<ѻýҕl>What's a Normal PSA Value for Transgender Women on Estrogen Therapy?ѻýҕl> Study suggests threshold is too high to identify risk of prostate cancer in this population Jun 26, 2024
<ѻýҕl>Oncology Drug Shortages Persist, but Continue to Evolveѻýҕl> Supply-chain issues, unrealistically low prices for generics, hoarding, other factors to blame Jun 26, 2024
<ѻýҕl>Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancerѻýҕl> Adding the mTOR inhibitor didn't improve EFS in intermediate-risk rhabdomyosarcoma Jun 25, 2024
<ѻýҕl>Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injuryѻýҕl> Case reports may not be as reliable, researchers say Jun 25, 2024
<ѻýҕl>Combo of Approved Agents Active in High-Risk Large B-Cell Lymphomaѻýҕl> Our panel of experts discusses mosunetuzumab/polatuzumab vedotin for relapsed/refractory patients Jun 25, 2024 video
<ѻýҕl>Acupuncture Reduced Hot Flashes Related to Endocrine Therapy for Breast Cancerѻýҕl> 64% of women reported at least a 50% reduction in hot flash frequency and severity Jun 24, 2024
<ѻýҕl>Subcutaneous C5 Inhibitor Approved for PNHѻýҕl> Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
<ѻýҕl>Treating Advanced Breast Cancer After Progression on CDK4/6 Inhibitorsѻýҕl> Results from postMONARCH offer one path Jun 24, 2024 video
<ѻýҕl>Court: Some Employers Can Exclude PrEP, Cancer Screenings From Insurance Coverageѻýҕl> Not all preventive care recommended by the USPSTF is threatened by the narrow ruling, however Jun 24, 2024
<ѻýҕl>Adagrasib Wins Accelerated Approval for KRAS-Mutant Colorectal Cancerѻýҕl> KRAS inhibitor plus cetuximab achieved 34% response rate, 85% disease control in early trial Jun 21, 2024
<ѻýҕl>ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancerѻýҕl> Clinical landscape has shifted away from traditional risks for H&N cancer to HPV predominance Jun 21, 2024
<ѻýҕl>ALK Inhibitor Shows Promise in Rare, Progressive Tumor Typesѻýҕl> Phase II study found brigatinib exceeded historical control by shrinking 10% of targeted tumors Jun 21, 2024
<ѻýҕl>EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancerѻýҕl> News, features, and commentary about cancer-related issues Jun 21, 2024
<ѻýҕl>Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLCѻýҕl> No significant difference between atezolizumab-cabozantinib, docetaxel for OS, PFS, response Jun 20, 2024
<ѻýҕl>Glofitamab Regimen Improves Survival in DLBCLѻýҕl> Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
<ѻýҕl>Using MRD Status to Deescalate Multiple Myeloma Therapyѻýҕl> Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
<ѻýҕl>Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCLѻýҕl> High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
<ѻýҕl>Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopeniaѻýҕl> "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
<ѻýҕl>Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLLѻýҕl> Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
<ѻýҕl>Two New Immunotherapy-Chemo Options Approved for Endometrial Cancerѻýҕl> New indications for pembrolizumab and durvalumab in advanced disease Jun 17, 2024
<ѻýҕl>New Standard of Care in High-Risk Acute Promyelocytic Leukemia?ѻýҕl> All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
<ѻýҕl>I Tried to Protect My Mother From Dying in Pain. The Law Robbed Her of That Dignity.ѻýҕl> It's time to clear the roadblocks to Medical Aid in Dying in the U.S. Jun 16, 2024
<ѻýҕl>Train Eyes So Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Strokeѻýҕl> Also in TTHealthWatch: cancers subsequent to CAR-T therapy Jun 15, 2024 podcast
<ѻýҕl>Atezolizumab Consolidation Impresses in High-Risk DLBCLѻýҕl> Will 2-year DFS of 88%, OS of 96% renew interest in checkpoint inhibitor consolidation? Jun 14, 2024
<ѻýҕl>Kate Middleton Gives Cancer Updateѻýҕl> Princess of Wales says she's making "good progress" in treatment Jun 14, 2024
<ѻýҕl>Adding Isatuximab to Standard Backbone Prolongs PFS in Myelomaѻýҕl> Joseph Mikhael, MD, leads a roundtable discussion on two positive phase III trials from ASCO Jun 14, 2024 video